توقعات سوق علم الفيروسات في آسيا والمحيط الهادئ حتى عام 2028 - تأثير فيروس كورونا (COVID-19) والتحليل الإقليمي حسب النوع (الاختبار التشخيصي، وتقنيات مكافحة العدوى الفيروسية، والعلاجات المضادة للفيروسات، والإنترفيرونات)، والتطبيق (التهابات الجلد والأنسجة الرخوة، والتهابات الجهاز التنفسي، والتهابات الجهاز الهضمي، والجنس الأمراض المنقولة، والتهابات المسالك البولية، وغيرها)، والمستخدم النهائي (المستشفيات، ومختبرات التشخيص، وشركات الأدوية والتكنولوجيا الحيوية، والمعاهد البحثية والأكاديمية)

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Virology Market – By Type

1.3.2        APAC Virology Market – By Application

1.3.3        APAC Virology Market – By End User

1.3.4        APAC Virology Market– By Country

2.           APAC Virology Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Virology Market– Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Virology Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Viral Infectious Diseases

5.1.2        Increasing Product Launches

5.2         Market Restraints

5.2.1        Availability of Alternative Products and High Cost of Production of Products

5.3         Market Opportunities

5.3.1        Surging Growth in Several Economies

5.4         Future Trends

5.4.1        Continuous Demand for Cost-Effective Products

5.5         Impact Analysis

6.           Virology Market– APAC Analysis

6.1         APAC Virology Market Revenue Forecast and Analysis

7.           APAC Virology Market Analysis – By Type

7.1         Overview

7.2         APAC Virology Market Revenue Share, by Type (2021 and 2028)

7.3         Diagnostic Test

7.3.1        Overview

7.3.2        Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1          Overview

7.3.2.1.2          DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1          Overview

7.3.2.2.2          RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Others

7.3.2.3.1          Overview

7.3.2.3.2          Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Viral Infection Controlling Techniques

7.4.1        Overview

7.4.2        Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1          Active Prophylaxis

7.4.2.1.1          Overview

7.4.2.1.2          Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2          Passive Prophylaxis

7.4.2.2.1          Overview

7.4.2.2.2          Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Antiviral Therapeutics

7.5.1        Overview

7.5.2        Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1          Virucidal Agents

7.5.2.1.1          Overview

7.5.2.1.2          Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2          Antiviral Agents

7.5.2.2.1          Overview

7.5.2.2.2          Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3          Immunomodulators

7.5.2.3.1          Overview

7.5.2.3.2          Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Interferons

7.6.1        Overview

7.6.2        Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.           APAC Virology Market Analysis – By Application

8.1         Overview

8.2         APAC Virology Market, by Application 2021 & 2028 (%)

8.3         Skin and Soft Tissue Infections

8.3.1        Overview

8.3.2        Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Respiratory Tract Infections

8.4.1        Overview

8.4.2        Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5         GI Tract Infections

8.5.1        Overview

8.5.2        GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Sexually Transmitted Diseases

8.6.1        Overview

8.6.2        Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Urinary Tract Infections

8.7.1        Overview

8.7.2        Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.           APAC Virology Market Analysis – By End User

9.1         Overview

9.2         APAC Virology Market Revenue Share, by End User (2021 and 2028)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Diagnostic Laboratories

9.4.1        Overview

9.4.2        Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Pharmaceutical and Biotechnological Companies

9.5.1        Overview

9.5.2        Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Research and Academic Institutes

9.6.1        Overview

9.6.2        Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.        APAC Virology Market – Country Analysis

10.1.1     Overview

10.1.2     Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)

10.1.2.1       China: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       China: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       China: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1    China: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.1.2.2    China: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.1.2.3    China: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.1.3       China: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4       China: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.2       Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       Japan: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1    Japan: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.2.2.2    Japan: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.2.2.3    Japan: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.2.3       Japan: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4       Japan: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.3       India: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       India: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       India: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1    India: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.3.2.2    India: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.3.2.3    India: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.3.3       India: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4       India: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.4       South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1       South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2       South Korea: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1    South Korea: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.4.2.2    South Korea: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.4.2.3    South Korea: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.4.3       South Korea: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4       South Korea: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.5       Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1       Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2       Australia: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1    Australia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.5.2.2    Australia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.5.2.3    Australia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.5.3       Australia: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4       Australia: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.6       Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1       Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2       Rest of Asia Pacific: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1    Rest of Asia Pacific: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.6.2.2    Rest of Asia Pacific: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.6.2.3    Rest of Asia Pacific: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.6.3       Rest of Asia Pacific: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4       Rest of Asia Pacific: Virology Market, by End User, 2019–2028 (USD Million)

11.        Impact of COVID-19 Pandemic on APAC Virology Market

11.1      Overview

12.        APAC Virology Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Abbott

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Johnson and Johnson Services, Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      F. HOFFMANN-LA ROCHE LTD.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      THERMO FISHER SCIENTIFIC INC.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      QIAGEN

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Illumina, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Siemens AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      GlaxoSmithKline Plc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      AbbVie Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Gilead Sciences, Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

Table 1.             APAC Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             China: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             China Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4.             China Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5.             China Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6.             China: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             China: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10.          Japan Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11.          Japan Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12.          Japan: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 13.          Japan: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          India: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 15.          India Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16.          India Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 17.          India Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18.          India: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19.          India: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Korea Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 22.          South Korea Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 23.          South Korea Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 24.          South Korea: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 25.          South Korea: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 26.          Australia: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 27.          Australia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 28.          Australia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 29.          Australia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 30.          Australia: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 31.          Australia: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32.          Rest of Asia Pacific: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 33.          Rest of Asia Pacific Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 34.          Rest of Asia Pacific Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 35.          Rest of Asia Pacific Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 36.          Rest of Asia Pacific: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 37.          Rest of Asia Pacific: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 38.          Organic Developments Done by Companies

Table 39.          Inorganic Developments Done by Companies

Table 40.          Glossary of Terms, APAC Virology Market

Figure 1.           APAC Virology Market Segmentation

Figure 2.           APAC Virology Segmentation, By Country

Figure 3.           APAC Virology Market Overview

Figure 4.           Antiviral Therapeutics Held the Largest Share of the Type Segment in APAC Virology Market

Figure 5.           Respiratory Tract Infections Held the Largest Share of the Application Segment in APAC Virology Market

Figure 6.           India to Show Significant Growth During Forecast Period

Figure 7.           APAC PEST Analysis

Figure 8.           APAC Virology Market: Impact Analysis of Drivers and Restraints

Figure 9.           APAC Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10.        APAC Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11.        APAC Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        APAC DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        APAC RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        APAC Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        APAC Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        APAC Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        APAC Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        APAC Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        APAC Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        APAC Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        APAC Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        APAC Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        APAC Virology Market, by Application 2021 & 2028 (%)

Figure 24.        APAC Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        APAC Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        APAC GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        APAC Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        APAC Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        APAC Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        APAC Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31.        APAC Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        APAC Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        APAC Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        APAC Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Asia Pacific: Virology Market, by Key Country – Revenue (2021) (USD Million)

Figure 36.        Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)

Figure 37.        China: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        India: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 42.        Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 43.        Impact of COVID-19 Pandemic on Virology Market in APAC Countries

1. Abbott
2. AbbVie Inc.
3. F. Hoffmann-La Roche Ltd.
4. Gilead Sciences, Inc.
5. GlaxoSmithKline Plc
6. Illumina, Inc.
7. Johnson and Johnson Services, Inc.
8. QIAGEN
9. Siemens AG
10. Thermo Fisher Scientific Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC Virology market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the APAC Virology market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution